Ocugen, Inc.
$471.41M- Market cap
- $461.19M
- Debt
- +$28.79M
- Cash
- −$18.57M
Capital structure 94% equity / 6% debt · EV / Revenue 106.82x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $461.19M · View financials
Snapshot Sep 4, 4:00 PM ET
Decision snapshot: OCGN stock price at premium vs FCPT $1.36 current versus $0.12 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FCPT's multiple
Implied fair value · at OCGN's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OCGN FY 2025 (ended Dec 31, 2025) · FCPT FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 106.82x
Capital structure 69% equity / 31% debt · EV / Revenue 13.36x · EV / EBITDA 17.41x
FCPT carries the larger enterprise value at $3.93B against $471.41M; FCPT trades on the lower EV / Revenue multiple (13.36x vs 106.82x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OCUGEN, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Four Corners Property Trust, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-2.37x
0.74x
Net debt / EBITDA
Leverage against operating earnings
-0.16x
5.28x
Cash and equivalents
Liquid reserves on the balance sheet
$18.57M
$12.14M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
IOVANCE BIOTHERAPEUTICS, INC.
OCGN vs IOVA
bluebird bio, Inc.
OCGN vs BLUE
BioNTech SE
OCGN vs BNTX
Moderna, Inc.
OCGN vs MRNA
Legend Biotech Corp
OCGN vs LEGN
Arcturus Therapeutics Holdings Inc.
OCGN vs ARCT
REALTY INCOME CORP
OCGN vs O
AGREE REALTY CORP
OCGN vs ADC
GETTY REALTY CORP /MD/
OCGN vs GTY
ESSENTIAL PROPERTIES REALTY TRUST, INC.
OCGN vs EPRT
STAG Industrial, Inc.
OCGN vs STAG
$28.79M
$1.20B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.